These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6175561)
1. Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis. Uchida A; Maida EM; Lenzhofer R; Micksche M Immunobiology; 1982 Feb; 160(5):392-402. PubMed ID: 6175561 [TBL] [Abstract][Full Text] [Related]
2. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients]. Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. Santoli D; Hall W; Kastrukoff L; Lisak RP; Perussia B; Trinchieri G; Koprowski H J Immunol; 1981 Apr; 126(4):1274-8. PubMed ID: 6162885 [TBL] [Abstract][Full Text] [Related]
4. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. Neighbour PA; Grayzel AI; Miller AE Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920 [TBL] [Abstract][Full Text] [Related]
5. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor. Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232 [TBL] [Abstract][Full Text] [Related]
6. Natural killer cell activity in patients with multiple sclerosis given alpha interferon. Rice GP; Casali P; Merigan TC; Oldstone MB Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954 [TBL] [Abstract][Full Text] [Related]
7. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit. Braakman E; van Tunen A; Meager A; Lucas CJ Clin Exp Immunol; 1986 Nov; 66(2):285-94. PubMed ID: 2949897 [TBL] [Abstract][Full Text] [Related]
8. [Interferon production and natural killer activity of peripheral blood lymphocytes obtained from patients with multiple sclerosis]. Maruo Y Hokkaido Igaku Zasshi; 1988 Jul; 63(4):521-33. PubMed ID: 2464533 [TBL] [Abstract][Full Text] [Related]
9. [The effect of sera of breast cancer patients on NK cell activity]. Konjević G; Spuzić I Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436 [TBL] [Abstract][Full Text] [Related]
10. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity. Graves SS; Bramhall J; Bonavida B J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588 [TBL] [Abstract][Full Text] [Related]
11. [The natural cytotoxicity system in patients with multiple sclerosis: clinico-immunological parallels]. Cheknev SB; Latysheva OL; Demina TL; Sorokin AM; Gusev EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):16-9. PubMed ID: 2800805 [TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102 [TBL] [Abstract][Full Text] [Related]
14. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity. Edwards BS; Hawkins MJ; Borden EC Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292 [TBL] [Abstract][Full Text] [Related]
15. The regulatory role of natural killer cells in multiple sclerosis. Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129 [TBL] [Abstract][Full Text] [Related]
17. Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy. Martínez-Rodríguez JE; Saez-Borderías A; Munteis E; Romo N; Roquer J; López-Botet M Clin Immunol; 2010 Oct; 137(1):41-50. PubMed ID: 20580616 [TBL] [Abstract][Full Text] [Related]
18. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity. Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907 [TBL] [Abstract][Full Text] [Related]
19. Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients. Lucero MA; Fridman WH; Provost MA; Billardon C; Pouillart P; Dumont J; Falcoff E Cancer Res; 1981 Jan; 41(1):294-9. PubMed ID: 6160906 [TBL] [Abstract][Full Text] [Related]
20. Effect of interferons on the inhibition of human natural killers by primary monolayer cell cultures. Heiskala M Immunology; 1987 Feb; 60(2):167-72. PubMed ID: 2434416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]